Researchers
Drulović, Jelena
Results 61-80 of 387
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2022 | Sudomotor dysfunction in people with neuromyelitis optica spectrum disorders![]() | Habek, Mario; Andabaka, Marko M. | Conference Paper | Mp. category will be shown later |
| 2022 | Ocrelizumab associated late-onset neutropenia in the patient with multiple sclerosis - case report and literature review![]() | Jovićević, Vanja; Bila, Jelena S. | Article | 23M23 |
| 2022 | Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: final safety and efficacy results from the phase 3 EVOLVE-MS-1 study![]() | Singer, Barry A.; Drulović, Jelena S.
Shankar, Sai L.; Wray, Sibyl;
| Conference Paper | Mp. category will be shown later |
| 2022 | In utero exposure to maternal anti-aquaporin-4 antibodies alters brain vasculature and neural dynamics in male mouse offspring![]() | Mader, Simone; ...; Dujmović, Irena | Article | 21a+M21a+ |
| 2022 | Performance of the 2017 and 2010 Revised McDonald Criteria in Predicting MS Diagnosis After a Clinically Isolated Syndrome A MAGNIMS Study![]() | Filippi, Massimo; ...; Mesaroš, Šarlota T. | Article | 21a+M21a+ |
| 2022 | MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis![]() | De Vito, Francesca; ...; Drulović, Jelena S. | Article | 21aM21a |
| 2022 | Rare variants and HLA haplotypes associated in patients with neuromyelitis optica spectrum disorders![]() | Tabansky, Inna; ...; Dujmović, Irena | Article | 21aM21a |
| 2022 | Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w-ratio: a multicenter study![]() | Margoni, Monica; ...; Mesaroš, Šarlota T. | Conference Paper | Mp. category will be shown later |
| 2022 | Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in a Large Cohort of Relapsing-Remitting MS Patients![]() | Drulović, Jelena | Article | 22M22 |
| 2022 | Humoral response to SARS-CoV-2 infection and vaccines against COVID-19 in patients with neuromyelitis optica spectrum disorders: Impact of immunosuppressive treatment![]() | Jovicevic, Vanja; Ivanovic, Jovana B; Momcilovic, Nikola; Andabaka, Marko M; Tamas, Olivera S; Veselinovic, Nikola D; Cujic, Danica | Contribution to periodical | 21M21 |
| 2022 | Application of deep-learning to the seronegative side of the NMO spectrum![]() | Cacciaguerra, Laura; Storelli, Loredana; Radaelli, Marta; Mesaroš, Šarlota T. | Article | 21aM21a |
| 2022 | Phenotypic and Genetic Heterogeneity of Adult Patients with Hereditary Spastic Paraplegia from Serbia![]() | Perić, Stojan | Article | 21M21 |
| 2022 | Sudomotor dysfunction in people with neuromyelitis optica spectrum disorders![]() | Habek, Mario; Andabaka, Marko M. | Article | 21aM21a |
| 2022 | Unilateral Left Frontal Lobe Lesion in a Marburg's Variant of Multiple Sclerosis Patient with Impaired Swallowing and Speech: A 3-Year Clinical/Brain MRI Follow-up![]() | Ivanović, Jovana B. | Article | 22M22 |
| 2022 | Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study![]() | Wray, Sibyl; ...; Drulović, Jelena S. | Article | 21M21 |
| 2022 | Impact of comorbidities on the disability progression in multiple sclerosis![]() | Marić, Gorica D. | Article | 21M21 |
| 2022 | Transverse myelitis following COVID-19: Insights from a multi-center study and systematic literature review![]() | Adamec, Ivan; ...; Drulović, Jelena S.
(broj koautora 16);
| Article | 21M21 |
| 2022 | Exploring in vivo multiple sclerosis brain microstructural damage through T1w/T2w ratio: a multicentre study![]() | Margoni, Monica; ...; Mesaroš, Šarlota T. | Article | 21a+M21a+ |
| 2021 | Application of Deep-Learning to NMOSD and Seronegative Patients with Limited NMOSD Manifestations![]() | Cacciaguerra, Laura; Storelli, Loredana; Radaelli, Marta; Mesaroš, Šarlota T. | Conference Paper | Mp. category will be shown later |
| 2021 | Interim Safety and Efficacy Outcomes in Patients With Relapsing-Remitting Multiple Sclerosis who Received Diroximel Fumarate for Up to 2 Years![]() | Wray, Sibyl; Singer, Barry A.; Drulović, Jelena S. | Conference Paper | Mp. category will be shown later |
